Verges 2014.
Methods | Randomised cross‐over double‐blinded placebo‐controlled trial |
Participants | Patients with statin‐treated type 2 diabetes |
Interventions | 40 mg/d long‐acting resveratrol vs placebo |
Outcomes | Changes in weight, HbA1c; lipid changes |
Study details | Two 3‐month periods |
Publication details | Conference abstract |
Stated aim of study | To study the effect of resveratrol on plasma lipids in patients with type 2 diabetes |
Notes | This is a conference abstract with no author contact information provided to obtain study data |
3MS: Modified Mini Mental State Examination, AC: arterial compliance, BMI: body mass index, BP: blood pressure, CVR: cerebral vasodilator responsiveness, HbA1c: glycosylated haemoglobin A1c, MCA: middle cerebral artery, TCD: transcranial doppler, T2DM: type 2 diabetes mellitus.